H/L Ventures is a company-building ecosystem that helps mission-driven founders build valuable companies. They combine daily active engagement with portfolio companies and a focus on growth, impact, and diversity. Their unique model aligns the interests of entrepreneurs, investors, and society for mutual success.

The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

JME Ventures is a seed-stage investor focusing on Spanish startups with great founders building world-class solutions. They invest between €100k and €3m and prioritize a fast, transparent process while empowering founders.

Ysios Capital is a leading European venture capital firm focused on life sciences. They invest globally in biotech ventures developing novel therapeutic drugs, supporting companies through preclinical and clinical development. Their investment thesis prioritizes strong scientific foundations, exceptional teams, and indications with high unmet medical needs.

Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.

Vital Venture Capital, LLC is a venture capital group that makes private investments in businesses where they possess above-average knowledge and experience. They aim to connect with management and nurture businesses toward success, focusing on providing growth capital and leveraging their expertise to generate attractive investment returns.

The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry. They deploy an edge-to-edge investment model, supporting companies from inception through exit. TCG has a two-decade history of nurturing science into successful ventures and therapeutic breakthroughs.

Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans. They invest in opportunities targeting unmet medical needs in commercially attractive markets, prioritizing companies with strong management teams and suitable for M&A exits.

Lockheed Martin Ventures makes strategic investments in companies developing cutting-edge technologies in core businesses and new markets important to Lockheed Martin. It provides portfolio companies with access to Lockheed Martin's engineering talent, technologies, research, international business relationships, and supply chain.

Lumira Ventures is a leading Canadian life sciences venture capital firm investing in and helping to create value in transformative life sciences companies. They focus on biotech, medtech, and healthcare companies transforming global healthcare through innovation, aiming for exceptional returns while delivering impact to patients.

Robert Bosch Venture Capital GmbH (RBVC) invests in deep-tech companies worldwide, focusing on early-stage ventures with a potential to shape the future of human living spaces. RBVC offers financial commitment and access to Bosch's vast network, supporting commercial collaborations. Their investment sweet spot is early stage, but they also consider later-stage and seed-stage companies in select cases.

Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients. They build sustainable companies that translate scientific innovation to transform patients' lives by fostering collaboration among experts in science, medicine, business, and strategy.